HDT BIO
Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
Emcure Pharma gets relief in $950-million lawsuitThe US district judge James Robart upheld the Indian drug maker's argument that the court lacked jurisdiction over the company and dismisse...
Here’s why developing countries can make COVID-19 mRNA vaccinesDepending on wealthy nations to donate billions of doses is not working, public health experts say. The solution, many now believe, is for ...
Gennova Biopharma to start mRNA vaccine trials by the year's end; results likely in March '21The trial results are likely to come in by March 2021, Sanjay Singh, CEO of Pune-based Gennova, told ET. There is a possibility that India ...
Human clinical trials of Gennova’s mRNA COVID-19 vaccine to start by the end of this yearPune-based biotechnology company Gennova Biopharmaceuticals will soon start human clinical trials of a Covid-19 vaccine candidate, joining ...
Load More